VELVET, a Dose Range Finding Trial of Veltuzumab in Subjects With Moderate to Severe Rheumatoid Arthritis

NCT01390545 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
300
Enrollment
INDUSTRY
Sponsor class

Stopped Trial re-design; no safety issues identified

Conditions

Interventions

Sponsor

Takeda